Assessment of vascular dysfunction in patients without obstructive coronary artery disease: why, how, and when

TJ Ford, P Ong, U Sechtem, J Beltrame… - Cardiovascular …, 2020 - jacc.org
Ischemic heart disease secondary to coronary vascular dysfunction causes angina and
impairs quality of life and prognosis. About one-half of patients with symptoms and signs of …

Stable coronary syndromes: pathophysiology, diagnostic advances and therapeutic need

TJ Ford, D Corcoran, C Berry - Heart, 2018 - heart.bmj.com
The diagnostic management of patients with angina pectoris typically centres on the
detection of obstructive epicardial CAD, which aligns with evidence-based treatment options …

Myocardial Perfusion PET for the Detection and Reporting of Coronary Microvascular Dysfunction: A JACC: Cardiovascular Imaging Expert Panel Statement

TH Schindler, WF Fearon, M Pelletier-Galarneau… - Cardiovascular …, 2023 - jacc.org
Angina pectoris and dyspnea in patients with normal or nonobstructive coronary vessels
remains a diagnostic challenge. Invasive coronary angiography may identify up to 60% of …

Stratified medical therapy using invasive coronary function testing in angina: the CorMicA trial

TJ Ford, B Stanley, R Good, P Rocchiccioli… - Journal of the American …, 2018 - jacc.org
Background: Patients with angina symptoms and/or signs of ischemia but no obstructive
coronary artery disease (INOCA) pose a diagnostic and therapeutic challenge. Objectives …

Prevalence of coronary artery disease and coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction

CJ Rush, C Berry, KG Oldroyd, JP Rocchiccioli… - JAMA …, 2021 - jamanetwork.com
Importance Coronary artery disease (CAD) and coronary microvascular dysfunction (CMD)
may contribute to the pathophysiologic characteristics of heart failure with preserved ejection …

1-year outcomes of angina management guided by invasive coronary function testing (CorMicA)

TJ Ford, B Stanley, N Sidik, R Good… - Cardiovascular …, 2020 - jacc.org
Objectives The aim of this study was to test the hypothesis that invasive coronary function
testing at time of angiography could help stratify management of angina patients without …

Post-stenting fractional flow reserve vs coronary angiography for optimization of percutaneous coronary intervention (TARGET-FFR)

D Collison, M Didagelos… - European Heart …, 2021 - academic.oup.com
Aims A fractional flow reserve (FFR) value≥ 0.90 after percutaneous coronary intervention
(PCI) is associated with a reduced risk of adverse cardiovascular events. TARGET-FFR is an …

Systemic microvascular dysfunction in microvascular and vasospastic angina

TJ Ford, P Rocchiccioli, R Good… - European heart …, 2018 - academic.oup.com
Aims Coronary microvascular dysfunction and/or vasospasm are potential causes of
ischaemia in patients with no obstructive coronary artery disease (INOCA). We tested the …

Ischemia and no obstructive coronary artery disease: prevalence and correlates of coronary vasomotion disorders

TJ Ford, E Yii, N Sidik, R Good… - Circulation …, 2019 - Am Heart Assoc
Background: Determine the prevalence and correlates of microvascular and vasospastic
angina in patients with symptoms and signs of ischemia but no obstructive coronary artery …

Effect of low-dose intracoronary alteplase during primary percutaneous coronary intervention on microvascular obstruction in patients with acute myocardial infarction …

PJ McCartney, H Eteiba, AM Maznyczka, M McEntegart… - Jama, 2019 - jamanetwork.com
Importance Microvascular obstruction commonly affects patients with acute ST-segment
elevation myocardial infarction (STEMI) and is associated with adverse outcomes. Objective …